Small study shows promise for antimalarial monoclonal antibody to prevent malaria

Focused chemists in lab coats and safety goggles making experiments.

A monoclonal antibody treatment was found to be safe, well tolerated, and effective in protecting against malaria in a small group of healthy volunteers who were exposed to malaria in a challenge study, according to new research published in The Lancet Infectious Diseases by researchers at the University of Maryland School of Medicine (UMSOM).

Researchers discover a key role played by ch-TOG protein in the initiation of microtubule assembly

Previous article

Survey: Trust in genetics increased significantly during the pandemic

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Innovations